{"id":"fenoxypropazine","rwe":[],"tags":[{"label":"fenoxypropazine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"phenoxypropazine","offLabel":[],"synonyms":["fenoxypropazine","2-Hydrazino-1-phenoxypropane","phenoxypropazine"],"timeline":[],"approvals":[],"brandName":"Phenoxypropazine","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"fenoxypropazine","explanation":"Imagine your body's cells are like locks, and phenoxypropazine is a key that fits into one of those locks. When it binds to the lock, it can either turn it on or off, depending on the type of lock and the key's shape. However, since we don't know what lock phenoxypropazine binds to, we can't say exactly how it works or what effects it has on the body.","oneSentence":"Phenoxypropazine is a small molecule that works by interacting with a specific target in the body, but its exact mechanism of action is unknown.","technicalDetail":"Phenoxypropazine is a small molecule that likely interacts with a specific protein or receptor in the body, but its precise binding site and mechanism of action are unknown."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Phenoxypropazine","title":"Phenoxypropazine","extract":"Phenoxypropazine is an irreversible and non-selective monoamine oxidase inhibitor (MAOI) of the hydrazine family. It was introduced as an antidepressant in 1961, but was subsequently withdrawn in 1966 due to hepatotoxicity concerns."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3814","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=fenoxypropazine","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://en.wikipedia.org/wiki/Phenoxypropazine","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T11:15:32.812405","biosimilars":[],"competitors":[],"genericName":"fenoxypropazine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"8E92V52324","CHEBI":"CHEBI:134799","INN_ID":"1235","UMLSCUI":"C2347504","ChEMBL_ID":"CHEMBL1909286","DRUGBANK_ID":"DB09251","PUBCHEM_CID":"71467"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Phenoxypropazine is a small molecule drug of the fenoxypropazine class, but its target and mechanism of action are unknown. Its commercial status, including FDA approval, half-life, bioavailability, generic manufacturers, and off-patent status, are also unclear. As a result, there is limited information available on its approved indications, key safety considerations, and clinical use. Further research is needed to understand the pharmacology and clinical utility of phenoxypropazine. Its development history is also unclear, with no information available on its original developer or current owner.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}